ctrl K

Price Alert

Lexicon Pharmaceuticals I... (LXRX)

NASDAQ: LXRX · Real-Time Price · USD

1.15

-0.01 (-0.86%)

At close: Aug 20, 2025, 9:47 AM

Lexicon Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	66.66M	22.46M	46.34M	64.06M
Short-Term Investments	171.3M	147.56M	92.01M	22.68M
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	368K	828K	412K	2.27M
Receivables	3.47M	1.01M	28K	14K
Inventory	231K	381K	n/a	n/a
Other Current Assets	4.53M	5.13M	2.48M	2.16M
Total Current Assets	246.19M	176.55M	140.87M	88.92M
Property-Plant & Equipment	7.32M	7.51M	8.48M	1.18M
Goodwill & Intangibles	44.54M	44.54M	44.54M	44.54M
Total Long-Term Assets	52.23M	52.88M	53.43M	47.99M
Total Assets	298.42M	229.43M	194.3M	136.91M
Account Payables	14.8M	14.39M	10.39M	9.15M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	14.71M	9.59M	3.66M	n/a
Total Current Liabilities	45.25M	31.55M	23.17M	22.12M
Long-Term Debt	100.3M	99.51M	48.58M	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	107.22M	104.77M	54M	1.19M
Total Liabilities	152.47M	136.32M	77.17M	23.31M
Total Debt	108.4M	106.06M	55.29M	2.28M
Common Stock	363K	245K	189K	150K
Retained Earnings	-1.97B	-1.77B	-1.59B	-1.49B
Comprehensive Income	119K	31K	-428K	-10K
Shareholders Equity	145.95M	93.11M	117.12M	-1.49B
Total Investments	171.3M	147.56M	92.01M	22.68M